TNON
Income statement / Annual
Last year (2023), Tenon Medical, Inc.'s total revenue was $2.93 M,
an increase of 323.73% from the previous year.
In 2023, Tenon Medical, Inc.'s net income was -$15.58 M.
See Tenon Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$2.93 M |
$691,000.00 |
$159,800.00 |
$43,820.00 |
$53,640.00 |
| Cost of Revenue |
$1.69 M
|
$1.33 M
|
$54,772.00
|
$18,257.00
|
$18,257.00
|
| Gross Profit |
$1.24 M
|
-$641,000.00
|
$105,028.00
|
$25,563.00
|
$35,383.00
|
| Gross Profit Ratio |
0.42
|
-0.93
|
0.66
|
0.58
|
0.66
|
| Research and Development Expenses |
$3.16 M
|
$2.83 M
|
$1.72 M
|
$220,884.00
|
$371,545.00
|
| General & Administrative Expenses |
$7.03 M
|
$7.42 M
|
$2.71 M
|
$311,667.00
|
$171,662.00
|
| Selling & Marketing Expenses |
$6.78 M
|
$7.83 M
|
$2.14 M
|
$29,301.00
|
$25,618.00
|
| Selling, General & Administrative Expenses |
$13.81 M
|
$15.26 M
|
$4.85 M
|
$340,968.00
|
$197,280.00
|
| Other Expenses |
$0.00
|
-$18,000.00
|
-$1,233.00
|
-$1,230.00
|
$0.00
|
| Operating Expenses |
$16.97 M
|
$18.08 M
|
$6.57 M
|
$561,852.00
|
$568,825.00
|
| Cost And Expenses |
$18.66 M
|
$19.42 M
|
$6.62 M
|
$580,109.00
|
$587,082.00
|
| Interest Income |
$0.00
|
$174,000.00
|
$619,000.00
|
$167,846.00
|
$52,358.00
|
| Interest Expense |
$21,000.00
|
$354,000.00
|
$620,808.00
|
$167,846.00
|
$52,358.00
|
| Depreciation & Amortization |
$199,000.00
|
$289,000.00
|
$113,980.00
|
$536,289.00
|
$533,442.00
|
| EBITDA |
-$15.53 M |
-$18.27 M |
-$6.35 M |
-$537,519.00 |
-$30.00 |
| EBITDA Ratio |
-5.3
|
-26.71
|
-39.72
|
-12.27
|
-9.94
|
| Operating Income Ratio |
-5.37
|
-27.1
|
-40.43
|
-12.24
|
-9.94
|
| Total Other Income/Expenses Net |
$146,000.00
|
-$192,000.00
|
-$619,734.00
|
-$169,076.00
|
-$52,388.00
|
| Income Before Tax |
-$15.58 M
|
-$18.92 M
|
-$7.08 M
|
-$705,365.00
|
-$585,828.00
|
| Income Before Tax Ratio |
-5.32
|
-27.38
|
-44.31
|
-16.1
|
-10.92
|
| Income Tax Expense |
$0.00
|
$192,000.00
|
$587,239.00
|
$47,659.00
|
-$609,690.00
|
| Net Income |
-$15.58 M
|
-$19.11 M
|
-$7.67 M
|
-$753,024.00
|
-$509,580.00
|
| Net Income Ratio |
-5.32
|
-27.65
|
-47.98
|
-17.18
|
-9.5
|
| EPS |
-68.71 |
-23.86 |
-6.82 |
-0.67 |
-0.45 |
| EPS Diluted |
-68.71 |
-23.86 |
-6.82 |
-0.67 |
-0.45 |
| Weighted Average Shares Out |
$226,750.00
|
$800,800.00
|
$1.12 M
|
$1.12 M
|
$1.12 M
|
| Weighted Average Shares Out Diluted |
$226,750.00
|
$800,800.00
|
$1.12 M
|
$1.12 M
|
$1.12 M
|
| Link |
|
|
|
|
|
